TreatmentUpdate
189
May 2012
Bone Health
- Reduced bone density and HIV
- Building better bones
- Bone growth and shrinkage
- Changes in bone density among HIV-negative men, some of whom used tenofovir
- HIV and menopause
- Menopause and the risks and benefits of hormone therapy
- Higher rates of bone loss seen after menopause in HIV-positive women
- Long-term effect of zoledronate on bone health in HIV-positive men
- A placebo-controlled study of alendronate in HIV-positive people
- Understanding the risk/benefit of bone drugs
